Internal Medicine, Hematology & Oncology · Memphis, TN
NPI
1124241062
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
80 Humphreys Center Dr, #330
Memphis, TN, 38120
Phone (901) 752-6131
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
1,793 services
Medicare patients, 2024
213
Average age 72
Drug cost, 2024
$4.9M
1,712 prescriptions
Company payments, 2025
$8,534
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salil Goorha was code 99233 (hospital e&m - subsequent), 492 times for 53 patients. In total Salil Goorha billed 1,793 services in 22 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 492 | 53 | $86.24 | $42K |
| 99214 Office E&M - Established | Facility | 455 | 126 | $65.72 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 431 | 122 | $11.03 | $4,756 |
| 99215 Office E&M - Established | Facility | 72 | 36 | $102.46 | $7,377 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 65 | 39 | $11.96 | $777 |
| 99213 Office E&M - Established | Facility | 52 | 37 | $41.09 | $2,137 |
| 99214 Office E&M - Established | Office | 46 | 36 | $69.12 | $3,180 |
| 99223 Hospital E&M - Initial | Facility | 34 | 24 | $118.73 | $4,037 |
| 38222 Other Organ Systems | Facility | 30 | 23 | $52.32 | $1,570 |
| 99239 Hospital Discharge Management | Facility | 26 | 20 | $83.48 | $2,171 |
| 99205 Office E&M - New | Facility | 19 | 19 | $124.90 | $2,373 |
| 99213 Office E&M - Established | Office | 14 | 14 | $39.89 | $559 |
| 99204 Office E&M - New | Facility | 14 | 14 | $92.93 | $1,301 |
By year: 2022 $111K for 1,433 services; 2023 $94K for 1,165 services; 2024 $106K for 1,793 services.
Medicare prescription drug claims, 2024
In 2024, the drug Salil Goorha prescribed most often to Medicare patients was Acyclovir, with 216 prescriptions and refills. In total Salil Goorha wrote 1,712 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 216 | 323 | 53 | $3,146 |
| Venclexta Venetoclax | 90 | 90 | 17 | $327K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 56 | 56 | Under 11 | $1,432 |
| Posaconazole Generic | 54 | 54 | Under 11 | $92K |
| Prednisone Generic | 47 | 48 | 11 | $287 |
| Gabapentin Generic | 42 | 60 | 12 | $420 |
| Oxycodone Hcl Generic | 40 | 40 | Under 11 | $849 |
| Imbruvica Ibrutinib | 38 | 38 | Under 11 | $452K |
| Potassium Chloride Generic | 37 | 42 | 16 | $859 |
| Pantoprazole Sodium Generic | 37 | 73 | 15 | $374 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | 11 | $666 |
| Eliquis Apixaban | 33 | 43 | Under 11 | $25K |
| Amlodipine Besylate Generic | 31 | 43 | Under 11 | $118 |
| Dexamethasone Generic | 30 | 30 | Under 11 | $292 |
| Morphine Sulfate Er Morphine Sulfate | 29 | 29 | Under 11 | $1,362 |
Brand drugs: - claims; generic drugs: 1,201 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salil Goorha $8,534 ($8,534 in general payments such as food, travel and fees) from 40 companies. The largest payer was Pfizer Inc. with $4,674.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 13 | $4,674 |
| Janssen Biotech, Inc. JNJ | 19 | $357 |
| Celgene Corporation BMY | 14 | $341 |
| Daiichi Sankyo Inc. 4568.T | 9 | $211 |
| Kite Pharma, Inc. GILD | 7 | $210 |
| GlaxoSmithKline, LLC. GSK | 11 | $209 |
| Genzyme Corporation SNY | 8 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $168 |
| Abbvie Inc. ABBV | 7 | $163 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.